Eleison Pharmaceuticals IPO: How to Buy Eleison Pharmaceuticals Stock When It Goes Public

Eleison Pharmaceuticals is expected to go public soon. Here's what we know about the IPO — and how to buy Eleison Pharmaceuticals stock when it's available.

What we know about the Eleison Pharmaceuticals IPO

Eleison Pharmaceuticals filed a registration form with the US Securities and Exchange Commission (SEC) to go public on the Nasdaq under the ticker symbol ELSN. Not yet an official IPO, this is one of the first steps of taking a private company public.

The exact IPO date has not been announced. There's no news yet about how much the stock will cost when it goes public. We'll update this page with more information as it becomes available.

How to buy Eleison Pharmaceuticals stock when it starts trading

Once Eleison Pharmaceuticals goes public, you'll need a brokerage account to invest. Consider opening a brokerage account today so you're ready as soon as the stock hits the market.

Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
Open your brokerage account. Complete an application with your details.
Confirm your payment details. Fund your account.
Research the stock. Find the stock by name or ticker symbol – ELSN – and research it before deciding if it's a good investment for you.
Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.

Finder's picks for buying Eleison Pharmaceuticals stock when it goes public

Go to site

$0 commission trading
Instant withdrawals with a 1.75% fee
Supports 250+ cryptocurrencies
High-yield account earns up to 4.65% APY

Disclaimer

Go to site

Trade options, futures, options on futures, stocks, ETFs
$0 commission to close options
Pro-grade platform and risk analysis tools

Go to site

Trade $0 commission stocks, ETFs, and options with as little as $1
After-hours trading available
Earn 4.5% interest on uninvested cash with Gold
24/7 customer support

How do similar companies perform?

It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. Looking at the performance of similar companies can help you decide if now is a good time to buy Eleison Pharmaceuticals stock.

See how the following stocks are performing, and view details like market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield.

Company summary
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; Evolveimmune Therapeutics, Inc.; Genentech, Inc.; and Tentarix Biotherapeutics, LP. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Historical performance
Stock information
- Market capitalization: $299759960064
- P/E ratio: 59.1045
- PEG ratio: 0.4052
- Dividend yield: 0.0387%
Get more detailed information and learn how to buy ABBV.US stock
Company summary
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Historical performance
Stock information
- Market capitalization: $365645266944
- P/E ratio: 25.144
- PEG ratio: 0.9126
- Dividend yield: 0.0327%
Get more detailed information and learn how to buy JNJ.US stock
Company summary
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Historical performance
Stock information
- Market capitalization: $147455082496
- P/E ratio: 34.6933
- PEG ratio: 0.1884
- Dividend yield: 0.0646%
Get more detailed information and learn how to buy PFE.US stock

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

1 - 9 of 9

Name	Product USFST	Ratings	Available asset types	Stock trade fee	Minimum deposit	Cash sweep APY	Signup bonus
Tastytrade Finder Score: 4.4 / 5: ★★★★★ Tastytrade Finder Score: 4.4 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills	$0	$0	N/A	Get $50-$5,000	Competitive, capped options commissions, with a reliable trading platform designed for serious traders.	Go to site View details	loading Fetching your data...
Robinhood Finder Score: 4.5 / 5: ★★★★★ Robinhood Finder Score: 4.5 / 5: ★★★★★		★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	4.5%	Get a free stock	Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.	Go to site View details	loading Fetching your data...
OPTO Finder Score: 3.1 / 5: ★★★★★ OPTO Finder Score: 3.1 / 5: ★★★★★		★★★★★	Stocks, ETFs	$0	$0	N/A	Earn up to $300	AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.	Go to site View details	loading Fetching your data...
EXCLUSIVE eToro Finder Score: 4 / 5: ★★★★★ eToro Finder Score: 4 / 5: ★★★★★	EXCLUSIVE	★★★★★	Stocks, Options, ETFs, Cryptocurrency	$0	$0	4.9%	FINDER EXCLUSIVE: Get a guaranteed $15 bonus and $10 in free crypto	No commission stock, ETF and options trades, with 4.9% interest on your options account balance and no options contract fees.	Go to site View details	loading Fetching your data...
Public.com Finder Score: 4.3 / 5: ★★★★★ Public.com Finder Score: 4.3 / 5: ★★★★★		★★★★★	Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account	$0	$0	4.35%	Get up to $10,000 and transfer fees covered	Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.	Go to site View details	loading Fetching your data...
Stash Finder Score: 3.7 / 5: ★★★★★ Stash Finder Score: 3.7 / 5: ★★★★★		★★★★★	Stocks, ETFs	$0	$0	0.1%	Get $10 when you sign up and deposit $5	Automated investing, individual stock and ETF investing and banking services for as low as $3 per month.	Go to site View details	loading Fetching your data...
Wealthfront Finder Score: 4.5 / 5: ★★★★★ Wealthfront Finder Score: 4.5 / 5: ★★★★★		★★★★★	Stocks, ETFs	$0	$500	5%	Get $50	Automated stock and bond ETF investing with the ability to trade individual stocks for as little as $1 apiece.	Go to site View details	loading Fetching your data...
Zacks Trade Finder Score: 3.8 / 5: ★★★★★ Zacks Trade Finder Score: 3.8 / 5: ★★★★★		★★★★★	Stocks, Bonds, Mutual funds, ETFs, CDs	$0.01	$250	2.83%	Get up to $500	Trade stocks, options, ETFs, mutual funds and bonds, with powerful trading tools and low margin rates.	Go to site View details	loading Fetching your data...
M1 Finance Finder Score: 4.1 / 5: ★★★★★ M1 Finance Finder Score: 4.1 / 5: ★★★★★		★★★★★	Stocks, ETFs, Cryptocurrency	$0	$100	4.25%	N/A	Build a custom portfolio of stocks and ETFs with automatic rebalancing. Plus, earn 4.25% APY with a high-yield cash account.	Go to site View details	loading Fetching your data...

loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

More on investing

How to buy FAANG stocks

Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.

Read more…

How to buy soccer stocks

A simple guide to buying stocks in your favorite European soccer team.

Read more…

Inflation stocks

Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.

Read more…

Thank you for your feedback!

More resources on Finder

How to buy SOS Hydration (SOSH) stock when it goes public How to buy Opti-Harvest (OPHV) stock when it goes public

More guides on Finder

Axos Bank Bonus Offers in November 2024
The $500 Axos Bank bonus is now expired, but you can still earn $50 per qualifying referral, plus up to $400 with a new business account.
Priority Plus Financial: Pushes Debt Relief Over Loans
Find out if Priority Plus Financial’s advertised loans are worth it or just a sales hook.
Xmas Loans: What, Where & How to Get Holiday Cash (2024)
Where to get a holiday loan in 2024 and whether it makes sense for you.
Modak vs. Greenlight: Which Kids’ Card Is Worth It?
Modak has no monthly fee, but it’s slim on features. Greenlight starts at $5.99 but is a value for big families.
Revenue-Based Business Loans: How Do They Work?
Get the capital your business needs to grow with repayments that adapt to your revenue.
Best Instant Cash Advance Apps
We’ve compared the best cash advance apps for quick cash — find the right one for your needs.
Beyond Finance Review: High Cost Debt Relief
A review of Beyond Finance, a company that offers debt settlement and consolidation loans.
How to Save $1,000 a Month
1. Make a budget 2. Create a savings plan 3. Automate savings 4. Pay yourself first 5. Use a high-yield account 6. Do a savings challenge…
How to Save $10,000 in a Year
To save $10K: 1. Automate savings 2. Invest 3. Budget 4. Open a high-yield savings account 5. Cut down on spending 6. Pay off debt…
Arrowhead Advance Review: High Cost Lender to Avoid
A review of Arrowhead Advance, a tribal lender that charges interest rates up to 830% and has numerous bad reviews.

Ask a question

Click here to cancel reply.

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

How to buy Eleison Pharmaceuticals (ELSN) stock when it goes public

Here's everything we know so far about the Eleison Pharmaceuticals IPO.

What we know about the Eleison Pharmaceuticals IPO

How to buy Eleison Pharmaceuticals stock when it starts trading